In the last 12 months, insiders at Arcadia Biosciences neither bought nor sold shares on the open market.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Stanley Jr Jacot | Chief Executive Officer | 5,000 | 0 | 5,000 | 47.0% | 30 May, 2023 |
| 2 | Thomas J. Schaefer | Chief Executive Officer | 2,819 | 0 | 2,819 | 26.5% | 05 Feb, 2025 |
| 3 | Mark Kawakami | Chief Financial Officer | 2,681 | 0 | 2,681 | 25.2% | 05 Feb, 2025 |
| 4 | Pamela Haley | Chief Financial Officer | 127 | 0 | 127 | 1.2% | 03 Aug, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 10 Sep, 2026 | Gregory D Waller | Director | Acquired A | 10,000 | $0.00 | $0 | 23,338 | Direct |
| 10 Sep, 2026 | Kevin Comcowich | Director | Acquired A | 23,000 | $0.00 | $0 | 54,042 | Direct |
| 10 Sep, 2026 | Lilian Shackelford Murray | Director | Acquired A | 10,000 | $0.00 | $0 | 23,287 | Direct |
| 10 Sep, 2026 | Amy Yoder | Director | Acquired A | 10,000 | $0.00 | $0 | 23,442 | Direct |
| 09 May, 2025 | Mark Kawakami | Chief Financial Officer | Acquired A | 12,500 | $0.00 | $0 | 33,987 | Direct |
| 09 May, 2025 | Thomas J. Schaefer | Chief Executive Officer | Acquired A | 12,500 | $0.00 | $0 | 37,975 | Direct |
| 03 Feb, 2025 | Mark Kawakami | Chief Financial Officer | Acquired P | 700 | $2.49 | $1.74K | 2,681 | Direct |
| 03 Feb, 2025 | Thomas J. Schaefer | Chief Executive Officer | Acquired P | 700 | $2.49 | $1.74K | 2,819 | Direct |
| 19 Aug, 2024 | Deborah D Carosella | Director | Acquired A | 10,909 | $0.00 | $0 | 13,255 | Direct |
| 19 Aug, 2024 | Amy Yoder | Director | Acquired A | 10,909 | $0.00 | $0 | 13,442 | Direct |
| 19 Aug, 2024 | Mark Kawakami | Chief Financial Officer | Acquired A | 20,000 | $0.00 | $0 | 21,487 | Direct |
| 19 Aug, 2024 | Albert D. Bolles | Director | Acquired A | 10,909 | $0.00 | $0 | 13,394 | Direct |
| 19 Aug, 2024 | Gregory D Waller | Director | Acquired A | 10,909 | $0.00 | $0 | 13,338 | Direct |
| 19 Aug, 2024 | Thomas J. Schaefer | Chief Executive Officer | Acquired A | 20,000 | $0.00 | $0 | 25,475 | Direct |
| 19 Aug, 2024 | Kevin Comcowich | Director | Acquired A | 25,455 | $0.00 | $0 | 31,042 | Direct |
| 01 Aug, 2024 | Thomas J. Schaefer | Chief Executive Officer | Acquired P | 700 | $2.06 | $1.44K | 2,119 | Direct |
| 19 Aug, 2024 | Lilian Shackelford Murray | Director | Acquired A | 10,909 | $0.00 | $0 | 13,287 | Direct |
| 01 Aug, 2024 | Mark Kawakami | Chief Financial Officer | Acquired P | 700 | $2.06 | $1.44K | 1,981 | Direct |
| 01 Feb, 2024 | Thomas J. Schaefer | Chief Financial Officer | Acquired P | 700 | $2.06 | $1.44K | 1,419 | Direct |
| 04 Aug, 2023 | Thomas J. Schaefer | Chief Financial Officer | Acquired P | 649 | $3.67 | $2.38K | 719 | Direct |